Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
Stock Information for Abeona Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.